LEADER 01499nam--2200433---450- 001 990001207830203316 005 20090908134724.0 010 $a88-8294-550-2 035 $a000120783 035 $aUSA01000120783 035 $a(ALEPH)000120783USA01 035 $a000120783 100 $a20031021d2003----km-y0enga50------ba 101 0 $aita 102 $aIT 105 $ay|||z|||001yy 200 1 $a<> codice della proprietà intellettuale e industriale$eaggiornato con il D.L.vo 9/4/03, n.68 di riforma del diritto d'autore$f[a cura di] Vincenzo Franceschelli, Emilio Tosi 205 $a3. ed 210 $aPiacenza$cLa Tribuna$d2003 215 $a1688 p.$d20 cm 225 2 $a<> codici commentati con la giurisprudenza 410 0$12001$a<> codici commentati con la giurisprudenza 606 0 $aDiritto d'autore$xLegislazione 606 0 $aProprietà industriale$xLegislazione 676 $a346.45048202632 702 1$aFRANCESCHELLI,$bVincenzo 702 1$aTOSI,$bEmilio 710 01$aITALIA$0423419 801 0$aIT$bsalbc$gISBD 912 $a990001207830203316 951 $aXXV.3.B 306 (CODEX 841 A)$b38898 G.$cXXV.3.B 306 (CODEX)$d00090568 959 $aBK 969 $aGIU 979 $aMARIA$b10$c20031021$lUSA01$h1024 979 $aRENATO$b90$c20040308$lUSA01$h1022 979 $aPATRY$b90$c20040406$lUSA01$h1726 979 $aRSIAV4$b90$c20090908$lUSA01$h1347 996 $aCodice della proprietà intellettuale e industriale$9878718 997 $aUNISA LEADER 01734nam 2200385 a 450 001 9910698865703321 005 20090512162300.0 035 $a(CKB)5470000002397207 035 $a(OCoLC)320854676 035 $a(EXLCZ)995470000002397207 100 $a20090512d2009 ua 0 101 0 $aeng 135 $aurcn||||a|||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aGuidance for industry$b[electronic resource] $eQ4B evaluation and recommendation of pharmacopoeial texts for use in the ICH region$hAnnex 4C$iMicrobiological examination of nonsterile products : acceptance criteria for pharmaceutical preparations and substances for pharmaceutical use general chapter 210 1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[2009] 215 $ai, 3 pages $cdigital, PDF file 300 $aTitle from title screen (viewed on May 12, 2009). 300 $a"April 2009." 320 $aIncludes bibliographical references (page 3). 517 $aGuidance for industry 606 $aPharmacopoeias$xStandards$xInternational cooperation 606 $aDrugs$xMicrobiology$xStandards$xInternational cooperation 615 0$aPharmacopoeias$xStandards$xInternational cooperation. 615 0$aDrugs$xMicrobiology$xStandards$xInternational cooperation. 712 02$aCenter for Drug Evaluation and Research (U.S.) 712 02$aCenter for Biologics Evaluation and Research (U.S.) 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910698865703321 996 $aGuidance for industry$93434577 997 $aUNINA